Locked Nucleic Acid, in oligonucleotides other than qPCR probes, is available in all countries except for the United States.
Locked Nucleic Acid is a novel type of nucleic acid analog that contains a 2'-O, 4'-C methylene bridge (Figure 1). This bridge–locked in the 3'-endo conformation–restricts the flexibility of the ribofuranose ring and locks the structure into a rigid bicyclic formation. This confers enhanced assay performance and an increased breadth of applications.
Figure 1.Structure of Locked Nucleic Acid and native-state DNA monomers.
Locked Nucleic Acid in PCR primers, qPCR probes, and other types of oligonucleotides is soluble in water and standard buffers as well as follows Watson-Crick base-pairing rules.1
When incorporated into oligonucleotides, Locked Nucleic Acid offers several benefits compared to native-state DNA bases only, including the following:
Incorporating Locked Nucleic Acid into oligonucleotides increases thermal duplex stability2 and improves the specificity of oligonucleotide hybridization to target sequences.3 In the case of qPCR, this reduces background fluorescence from spurious binding, which increases the signal-to-noise ratio. In addition, the improved hybridization of the PCR primer or qPCR probe to its target may increase the melting temperature (Tm) by up to 8 °C per Locked Nucleic Acid monomer substitution in medium salt conditions compared to native-state DNA oligonucleotides4 (Table 1). This increase in hybridization creates a significant broadening in the scope of assay conditions and allows for more successful multiplexing.5
*Tm of duplex between an oligonucleotide and its complementary sequence.
The bold letters in the sequences denote Locked Nucleic Acid bases.
The ability of oligonucleotides to discriminate between alleles via SNPs is greatly enhanced by the incorporation of Locked Nucleic Acid bases6-8 (Figure 2). The presence of a single base mismatch has a greater destabilizing effect on the duplex formation between an Locked Nucleic Acid oligonucleotide and its target than with a native-state DNA oligonucleotide. Shorter oligonucleotides incorporating Locked Nucleic Acid bases can be used at the same temperatures as longer native-state DNA oligonucleotides.
Figure 2.Locked Nucleic Acid Dual-Labeled Probes discriminate better than DNA Dual-Labeled Probes in SNP genotyping analysis9. Pink) mutant DNA analysis with Locked Nucleic Acid mutant probe (16mer with 3 Locked Nucleic Acid bases). Green) mutant DNA analysis with native-state DNA mutant probe (25mer). Red) wild-type DNA with native-state DNA mutant probe (25mer). Purple) wild-type DNA with Locked Nucleic Acid mutant Probe (16mer with 3 Locked Nucleic Acid bases).
Due to Locked Nucleic Acid’s improved hybridization characteristics with accompanied increase in Tm, Locked Nucleic Acid oligonucleotides can be synthesized to be shorter, which overcomes certain design limitations that occur with native-state DNA oligonucleotides. Specifically, Locked Nucleic Acid oligonucleotides can be designed to address traditionally problematic target sequences, such as AT- or GC-rich regions. For example, AT-rich native-state DNA oligonucleotides often need to be over 30 bases long (sometimes over 40 bases) to satisfy amplicon design guidelines but may still perform poorly. With Locked Nucleic Acid oligonucleotides, the selective placement of Locked Nucleic Acid bases facilitates the optimal design of highly-specific, shorter oligonucleotides that perform well, even at lengths of only 13 to 20 bases. Also, the design of oligonucleotides for targeting difficult SNPs, such as the relatively stable G:T mismatch, is greatly facilitated by Locked Nucleic Acid.
Locked Nucleic Acid PCR primers and qPCR probes are compatible with all real-time thermocyclers and end-point analytical detection instruments. No specialized instruments are necessary.
Locked Nucleic Acid can be incorporated into all available qPCR detection chemistries, including:
It is useful for the following:
It can also be used in these sequences:
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.